Submitted:
20 November 2026
Posted:
20 November 2026
You are already at the latest version
Abstract
Background/Objectives: Sustained adherence to antiretroviral therapy (ART) and pre-exposure prophylaxis (PrEP) is foundational to ending HIV, but objective, timely adherence monitoring outside clinical settings remains limited. Point-of-care tenofovir (POC TFV) testing, paired with a mobile app, could support adherence assessment and self-management, but end-user acceptability and required features to support adoption are understudied. Methods: Using a Human-Centered Design qualitative approach, we conducted focus groups and interviews with PrEP clients and with PrEP and ART clinicians, researchers, and experts about POC TFV testing in non-clinical settings, the potential role of a companion mobile app, and the desired features. Data were analyzed thematically using a consensus-refined codebook and compared with the digital health literature. Results: Sixteen people participated (10 Seattle PrEP clients; 6 PrEP and ART clinicians, researchers, and experts). Four themes emerged: client–provider trust, appropriate POC test use cases, high-value mobile app features, and differential utility across settings and populations. Participants would use POC TFV testing and an app when recommended by providers but viewed mandatory testing as a breach of trust. Participants distinguished appropriate from inappropriate POC use cases and wanted clear documentation of test applications and limitations. Desired app features included medication reminders, motivational content, and educational materials. Conclusions: Clients and clinicians saw a role for POC TFV testing with a mobile app if testing is voluntary, recommended by a trusted provider, and accompanied by clear information on what results do and do not show. Participants expected new PrEP clients and people with limited clinic access to benefit most; both expectations need testing in those groups.
Keywords:
pre-exposure prophylaxis
; antiretroviral therapy
; medication adherence
; point-of-care testing
; tenofovir
; mobile health
; human-centered design
; qualitative research
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.